147 related articles for article (PubMed ID: 24308002)
1. Development of an immunochromatographic test strip for detection of cholera toxin.
Yamasaki E; Sakamoto R; Matsumoto T; Morimatsu F; Kurazono T; Hiroi T; Nair GB; Kurazono H
Biomed Res Int; 2013; 2013():679038. PubMed ID: 24308002
[TBL] [Abstract][Full Text] [Related]
2. Immunochromatographic detection of the heat-labile enterotoxin of enterotoxigenic Escherichia coli with cross-detection of cholera toxin.
Arimitsu H; Sasaki K; Tsuji T
J Microbiol Methods; 2017 Jan; 132():148-152. PubMed ID: 27940044
[TBL] [Abstract][Full Text] [Related]
3. Detection of Cholera Toxin by an Immunochromatographic Test Strip.
Yamasaki E; Sakamoto R; Matsumoto T; Maiti B; Okumura K; Morimatsu F; Balakrish Nair G; Kurazono H
Methods Mol Biol; 2017; 1600():1-7. PubMed ID: 28478552
[TBL] [Abstract][Full Text] [Related]
4. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
[TBL] [Abstract][Full Text] [Related]
5. Concomitant enterotoxigenic Escherichia coli infection induces increased immune responses to Vibrio cholerae O1 antigens in patients with cholera in Bangladesh.
Chowdhury F; Begum YA; Alam MM; Khan AI; Ahmed T; Bhuiyan MS; Harris JB; LaRocque RC; Faruque AS; Endtz H; Ryan ET; Cravioto A; Svennerholm AM; Calderwood SB; Qadri F
Infect Immun; 2010 May; 78(5):2117-24. PubMed ID: 20176796
[TBL] [Abstract][Full Text] [Related]
6. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
Tokuhara D; Yuki Y; Nochi T; Kodama T; Mejima M; Kurokawa S; Takahashi Y; Nanno M; Nakanishi U; Takaiwa F; Honda T; Kiyono H
Proc Natl Acad Sci U S A; 2010 May; 107(19):8794-9. PubMed ID: 20421480
[TBL] [Abstract][Full Text] [Related]
7. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae.
Ryan ET; Crean TI; John M; Butterton JR; Clements JD; Calderwood SB
Infect Immun; 1999 Apr; 67(4):1694-701. PubMed ID: 10085006
[TBL] [Abstract][Full Text] [Related]
8. Specificity of the type II secretion systems of enterotoxigenic Escherichia coli and Vibrio cholerae for heat-labile enterotoxin and cholera toxin.
Mudrak B; Kuehn MJ
J Bacteriol; 2010 Apr; 192(7):1902-11. PubMed ID: 20097854
[TBL] [Abstract][Full Text] [Related]
9. Immunization against Vibrio cholerae, ETEC, and EHEC with chitosan nanoparticle containing LSC chimeric protein.
Ghaffari Marandi BH; Zolfaghari MR; Kazemi R; Motamedi MJ; Amani J
Microb Pathog; 2019 Sep; 134():103600. PubMed ID: 31202906
[TBL] [Abstract][Full Text] [Related]
10. Initial studies of the structural signal for extracellular transport of cholera toxin and other proteins recognized by Vibrio cholerae.
Connell TD; Metzger DJ; Wang M; Jobling MG; Holmes RK
Infect Immun; 1995 Oct; 63(10):4091-8. PubMed ID: 7558324
[TBL] [Abstract][Full Text] [Related]
11. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development.
Svennerholm AM
Indian J Med Res; 2011 Feb; 133(2):188-96. PubMed ID: 21415493
[TBL] [Abstract][Full Text] [Related]
12. Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae.
Weil AA; Ellis CN; Debela MD; Bhuiyan TR; Rashu R; Bourque DL; Khan AI; Chowdhury F; LaRocque RC; Charles RC; Ryan ET; Calderwood SB; Qadri F; Harris JB
mSphere; 2019 Aug; 4(4):. PubMed ID: 31434744
[No Abstract] [Full Text] [Related]
13.
Begum YA; Rydberg HA; Thorell K; Kwak YK; Sun L; Joffré E; Qadri F; Sjöling Å
mSphere; 2018; 3(1):. PubMed ID: 29404412
[TBL] [Abstract][Full Text] [Related]
14. Rapid and differential detection of two analogous enterotoxins of Vibrio cholerae and enterotoxigenic Escherichia coli by a modified enzyme-linked immunosorbent assay.
Koike N; Okada K; Yabushita Y; Zhang D; Yamamoto K; Miwatani T; Honda T
FEMS Immunol Med Microbiol; 1997 Jan; 17(1):21-5. PubMed ID: 9012440
[TBL] [Abstract][Full Text] [Related]
15. Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells.
Kauffman RC; Bhuiyan TR; Nakajima R; Mayo-Smith LM; Rashu R; Hoq MR; Chowdhury F; Khan AI; Rahman A; Bhaumik SK; Harris L; O'Neal JT; Trost JF; Alam NH; Jasinskas A; Dotsey E; Kelly M; Charles RC; Xu P; Kováč P; Calderwood SB; Ryan ET; Felgner PL; Qadri F; Wrammert J; Harris JB
mBio; 2016 Dec; 7(6):. PubMed ID: 27999163
[TBL] [Abstract][Full Text] [Related]
16. A polyclonal-monoclonal antibody based sensitive sandwich enzyme linked immunosorbent assay for specific detection of cholera toxin.
Bhadra RK; Biswas T; Pal SC; Takeda T; Nair GB
Zentralbl Bakteriol; 1991 Oct; 275(4):467-73. PubMed ID: 1755920
[TBL] [Abstract][Full Text] [Related]
17. Quantitative detection of Vibrio cholera toxin by real-time and dynamic cytotoxicity monitoring.
Jin D; Luo Y; Zheng M; Li H; Zhang J; Stampfl M; Xu X; Ding G; Zhang Y; Tang YW
J Clin Microbiol; 2013 Dec; 51(12):3968-74. PubMed ID: 24048535
[TBL] [Abstract][Full Text] [Related]
18. Dual-Use Vaccine for Diarrhoeal Diseases: Cross-Protective Immunogenicity of a Cold-Chain-Free, Live-Attenuated, Oral Cholera Vaccine against Enterotoxigenic
Hui Xian T; Parasuraman S; Ravichandran M; Prabhakaran G
Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560571
[TBL] [Abstract][Full Text] [Related]
19. Concomitant infection of enterotoxigenic Escherichia coli in an outbreak of cholera caused by Vibrio cholerae O1 and O139 in Ahmedabad, India.
Chakraborty S; Deokule JS; Garg P; Bhattacharya SK; Nandy RK; Nair GB; Yamasaki S; Takeda Y; Ramamurthy T
J Clin Microbiol; 2001 Sep; 39(9):3241-6. PubMed ID: 11526157
[TBL] [Abstract][Full Text] [Related]
20. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
Ruan X; Liu M; Casey TA; Zhang W
Clin Vaccine Immunol; 2011 Oct; 18(10):1593-9. PubMed ID: 21813665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
